NCT05477914 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Arkkola T, Uusitalo U, Pietikäinen M, Metsälä J, Kronberg-Kippilä C, Erkkola M, Veijola R, Knip M, Virtanen SM, Ovaskainen ML
Dietary intake and use of dietary supplements in relation to demographic variables among pregnant Finnish women. Br J Nutr. 2006 Nov;96(5):913-20.
Popa AD, Nita O, Graur Arhire LI, Popescu RM, Botnariu GE, Mihalache L, Graur M
Nutritional knowledge as a determinant of vitamin and mineral supplementation during pregnancy. BMC Public Health. 2013 Dec 1;13:1105. doi: 10.1186/1471-2458-13-1105.

Assesment of Knowledge,Attitude and Practice of Pregnant Women Regarding Iron,Folic Acid and Multivitamins at AlMonshah District.

Clinical trial NCT05477914 - References